Discovery and Early Clinical Development of LY3202626, a Low-Dose, CNS-Penetrant BACE Inhibitor

2021 ◽  
Author(s):  
David L. McKinzie ◽  
Leonard L. Winneroski ◽  
Steven J. Green ◽  
Erik J. Hembre ◽  
Jon A. Erickson ◽  
...  
Keyword(s):  
Low Dose ◽  
Clinical Development ◽  
Bace Inhibitor ◽  
Early Clinical Development

scholarly journals Drugs in early clinical development for Systemic Lupus Erythematosus

2016 ◽  
Vol 25 (5) ◽  
pp. 573-583 ◽  
Author(s):  
Mariana Postal ◽  
Nailú Angélica Sinicato ◽  
Simone Appenzeller ◽  
Timothy B. Niewold
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Lupus Erythematosus ◽  
Clinical Development ◽  
Systemic Lupus ◽  
Early Clinical Development

Abstract DDT02-03: Discovery of GDC-0994, a potent and selective ERK1/2 inhibitor in early clinical development

2014 ◽  
Author(s):  
Kirk Robarge ◽  
Jacob Schwarz ◽  
Jim Blake ◽  
Michael Burkard ◽  
Jocelyn Chan ◽  
...  
Keyword(s):  
Clinical Development ◽  
Early Clinical Development

Abstract 5582: Use of circulating tumor DNA (ctDNA) to predict superiority of dosing schedules in early clinical development

2018 ◽  
Author(s):  
Juliann Chmielecki ◽  
Zhongwu Lai ◽  
Kristy Potts ◽  
Kavita Garg ◽  
Mark Li ◽  
...  
Keyword(s):  
Circulating Tumor Dna ◽  
Clinical Development ◽  
Tumor Dna ◽  
Early Clinical Development
Sign in / Sign up

Export Citation Format

Share Document